Viral Gastroenteritis Market Research Report- Global Forecast till 2027

Viral Gastroenteritis Market Information: By Type of Virus (Norovirus, Rotavirus), By Diagnosis (Physical Examination, Rapid Stool Test), By Drugs (Antibiotics, Antacids, Laxatives, Antimotility Agents), By Indication (Watery Diarrhea, Vomiting) and By End Use (Hospitals, Clinics, Diagnostic Centers, others) -Forecast till 2027

ID: MRFR/Pharma/3027-HCR | February 2021 | Region: Global | 206 pages

Market Synopsis of the Viral Gastroenteritis Market:
Viral gastroenteritis, also known as stomach flu, is inflammation of the lining of the stomach, small intestine, and large intestine. There are a number of viruses leading viral gastroenteritis such as norovirus, rotavirus, astrovirus and enteric adenovirus. Norovirus and rotavirus are the most common causes of this disease. This disease is transmitted through direct contact with the patient, and contaminated water or food. The main focus of treating the disease is rehydration by drinking enough water or fluids.


The market for viral gastroenteritis is driven by an increasing prevalence of gastrointestinal diseases, availability of cost effective treatment and extensive research and development activities in internal medicine Furthermore, there is an increasing demand for the new drugs for the treatment of the disease.


Bacterial resistance to commonly used antibiotics such as penicillin and amoxicillin may be the leading restrain for the growth of the market. Fierce competition among key market players acts as a barrier for the new entrant in the market.


According to the World Health Organization (WHO), diarrheal diseases are a major cause of hospitalizations and child deaths globally.


The viral gastroenteritis market size is expected to grow at a CAGR of 7.5% during the forecast period.


FIGURE 1: Global Viral Gastroenteritis Market by Region, 2016 (%) Viral Gastroenteritis Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Key Players in the Global Viral Gastroenteritis Market 
Valeant Pharmaceuticals International Inc. (U.S.), Janssen Global Services, LLC U.S.), Takeda Pharmaceutical (Japan), Bayer AG (Germany), Sanofi (France), Allergan (Ireland), GlaxoSmithKline (U.S.), Abbott (U.S.),  and AstraZeneca (U.K).
Segments   
                                                                                                                                       
The global viral gastroenteritis market is segmented on the basis of type of virus, diagnosis, drugs, indication, and end user.


On the basis of type of virus, market is segmented into norovirus, rotavirus, astrovirus, and enteric adenovirus.


On the basis of diagnosis, the market is segmented into physical examination and rapid stool test.


On the basis of drugs, the market is segmented into Antibiotics, antacids, laxatives, antimotility agents and others. Other drugs are antiemetics and chemotherapy drugs.


On the basis of indication, the market is segmented into watery diarrhea, vomiting, abdominal cramps and pain and others.


On the basis of end user, the market is segmented into hospitals, clinics, pharmaceutical companies, diagnostic centers, ambulatory care centers and others.


Research Methodology Viral Gastroenteritis Market-

Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


 


 


Regional Analysis of the Global Viral Gastroenteritis Market               
America is the largest market for viral gastroenteritis owing to rising prevalence of viral gastroenteritis in the U.S., especially among the pediatric population. According to the Center For Disease Control And Prevention (CDC), each year on average in the United States, there are 19 to 21 million cases of acute gastroenteritis.


Europe is the second largest market for viral gastroenteritis. According to an article published in the journal of Clinical Virology, in Europe, acute infectious gastroenteritis is one of the major causes for substantial morbidity and economic loss.


In Asia Pacific, the common cause of severe gastroenteritis in children less than 5 years of age, is rotavirus. The market in Asia Pacific is driven by an increasing demand for rapid diagnostic tests for gastrointestinal diseases and increasing awareness about available treatment options for viral gastroenteritis. Also, growing investments in the field of life science research and demand for advanced therapies for the treatment of gastrointestinal diseases in developing nations such as China and India will propel the growth of the Asia Pacific market.


The Middle East & Africa also show a steady rise in the market owing to increasing number of cases of diarrhea due to viral infection.


 Intended Audience



  • Gastrointestinal Drug Manufacturers

  • Gastrointestinal Drug Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


Viral gastroenteritis market is projected to grow at a 7.5% CAGR between 2017- 2023.

The Americas is expected to dominate the viral gastroenteritis market.

Availability of cost effective treatment and rising prevalence of gastrointestinal diseases are the key factors driving the viral gastroenteritis market growth.

Fierce competition among industry players and bacterial resistance to antibiotics may limit the viral gastroenteritis market growth.

Leading players profiled in the viral gastroenteritis market include AstraZeneca (U.K), Abbott (U.S.), GlaxoSmithKline (U.S.), Allergan (Ireland), Sanofi (France), Bayer AG (Germany), Takeda Pharmaceutical (Japan), Janssen Global Services, LLC U.S.), and Valeant Pharmaceuticals International Inc. (U.S.).

BRIEF TOC

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Viral Gastroenteritis Market, by type of virus

6.1 Introduction

6.2 Norovirus

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Rotavirus

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Astrovirus

6.4.1 Market Estimates & Forecast, 2020-2027

6.5 Enteric adenovirus

6.5.1 Market Estimates & Forecast, 2020-2027

Chapter 7. Global Viral Gastroenteritis Market, by Diagnosis

7.1 Introduction

7.2 Physical Examination

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Rapid Stool Test

7.3.1 Market Estimates & Forecast, 2020-2027

Chapter 8. Global Viral Gastroenteritis Market, by Drugs

8.1 Introduction

8.2 Antibiotics

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Antacids

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Laxatives

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Antimotility agents

8.5.1 Market Estimates & Forecast, 2020-2027

8.6 Others

8.6.1 Market Estimates & Forecast, 2020-2027

Chapter 9. Global Viral Gastroenteritis Market, by Indication

9.1 Introduction

9.2 Watery Diarrhea

9.2.1 Market Estimates & Forecast, 2020-2027

9.3 Vomiting

9.3.1 Market Estimates & Forecast, 2020-2027

9.4 Abdominal cramps and pain

9.4.1 Market Estimates & Forecast, 2020-2027

9.5 Others

9.5.1 Market Estimates & Forecast, 2020-2027

Chapter 10. Global Viral Gastroenteritis Market, by End User

10.1 Introduction

10.2 Hospital

10.2.1 Market Estimates & Forecast, 2020-2027

10.3 Clinics

10.3.1 Market Estimates & Forecast, 2020-2027

10.3 Pharmaceutical Companies

10.3.1 Market Estimates & Forecast, 2020-2027

10.3 Diagnostic Centers

10.3.1 Market Estimates & Forecast, 2020-2027

10.3 Ambulatory Care Centers

10.3.1 Market Estimates & Forecast, 2020-2027

10.3 Others

10.3.1 Market Estimates & Forecast, 2020-2027

Chapter 11. Global Viral Gastroenteritis Market, by Region

11.1 Introduction

11.2 America

11.2.1 North America

11.2.1.1 US

11.2.1.1 Canada

11.2.2 South America

11.3 Europe

11.3.1 Western Europe

11.3.1.1 Germany

11.3.1.2 France

11.3.1.3 UK

11.3.1.4 Italy

11.3.1.5 Spain

11.3.1.6 Rest of Western Europe

11.3.2 Eastern Europe

11.4 Asia Pacific

11.4.1 Japan

11.4.2 China

11.4.3 India

11.4.4 Australia

11.4.5 Republic of Korea

11.4.6 Rest of Asia Pacific

11.5 The Middle East & Africa

11.5.1 United Arab Emirates

11.5.2 Saudi Arabia

11.5.3 Oman

11.5.4 Kuwait

11.5.5 Qatar

11.5.6 Rest of the Middle East & Africa

Chapter 12 Company Landscape

12.1 Introduction

12.2 Market Share Analysis

12.3 Key Development & Strategies

12.3.1 Key Developments

Chapter 13 Company Profiles

13.1 Valeant Pharmaceuticals

13.1.1 Company Overview

13.1.2 Product Overview

13.1.3 Financials

13.1.4 SWOT Analysis

13.2 Janssen Biotech Inc.

13.2.1 Company Overview

13.2.2 Product Overview

13.2.3 Financial Overview

13.2.4 Key Developments

13.2.5 SWOT Analysis

13.3 Takeda Pharmaceutical

13.3.1 Company Overview

13.3.2 Product Overview

13.3.3 Financial Overview

13.3.4 Key Development

13.3.5 SWOT Analysis

13.4 Abbott

13.4.1 Company Overview

13.4.2 Product/Business Segment Overview

13.4.3 Financial Overview

13.4.4 Key Development

13.4.5 SWOT Analysis

13.5 Bayer AG

13.5.1 Company Overview

13.5.2 Product Overview

13.5.3 Financial overview

13.5.4 Key Developments

13.6 Sanofi

13.6.1 Company Overview

13.6.2 Product Overview

13.6.3 Financial Overview

13.6.4 Key Developments

13.7 Allergan.

13.7.1 Overview

13.7.2 Product Overview

13.7.3 Financials

13.7.4 Key Developments

13.7.5 SWOT Analysis

13.8 Others

Chapter 14 MRFR Conclusion

14.1 Key Findings

14.1.1 From CEO’s View Point

14.1.2 Unmet Needs of the Market

14.2 Key Companies to Watch

14.3 Prediction of Pharmaceutical Industry

Chapter 15 Appendix

DATA TABLES

Table 1 Viral Gastroenteritis Industry Synopsis, 2020-2027

Table 2 Global Viral Gastroenteritis Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Viral Gastroenteritis Market by Region, 2020-2027, (USD Million)

Table 4 Global Viral Gastroenteritis Market by Type of Virus, 2020-2027, (USD Million)

Table 5 Global Viral Gastroenteritis Market by Diagnosis, 2020-2027, (USD Million)

Table 6 Global Viral Gastroenteritis Market by Drugs 2020-2027, (USD Million)

Table 7 Global Viral Gastroenteritis Market by Indication, 2020-2027, (USD Million)

Table 8 Global Viral Gastroenteritis Market by End Users, 2020-2027, (USD Million)

Table 9 North America Viral Gastroenteritis Market by Type of Virus, 2020-2027, (USD Million)

Table 10 North America Viral Gastroenteritis Market by Diagnosis, 2020-2027, (USD Million)

Table 11 North America Viral Gastroenteritis Market by End Users, 2020-2027, (USD Million)

Table 12 North America Viral Gastroenteritis Market by Drugs 2020-2027, (USD Million)

Table 13 North America Viral Gastroenteritis Market by Indication, 2020-2027, (USD Million)

Table 14 South America Viral Gastroenteritis Market by Type of Virus, 2020-2027, (USD Million)

Table 15 South America Viral Gastroenteritis Market by Diagnosis, 2020-2027, (USD Million)

Table 16 South America Viral Gastroenteritis Market by Drugs 2020-2027, (USD Million)

Table 17 South America Viral Gastroenteritis Market by Indication, 2020-2027, (USD Million)

Table 18 South America Viral Gastroenteritis Market by End Users, 2020-2027, (USD Million)

Table 19 Europe Viral Gastroenteritis Market by Type of Virus, 2020-2027, (USD Million)

Table 20 Europe Viral Gastroenteritis Market by Diagnosis, 2020-2027, (USD Million)

Table 21 Europe Viral Gastroenteritis Market by Drugs 2020-2027, (USD Million)

Table 22 Europe Viral Gastroenteritis Market by Indication, 2020-2027, (USD Million)

Table 23 Europe Viral Gastroenteritis Market by End Users, 2020-2027, (USD Million)

Table 24 Western Europe Viral Gastroenteritis Market by Type of Virus, 2020-2027, (USD Million)

Table 25 Western Europe Viral Gastroenteritis Market by Diagnosis, 2020-2027, (USD Million)

Table 26 Europe Viral Gastroenteritis Market by Drugs 2020-2027, (USD Million)

Table 27 Europe Viral Gastroenteritis Market by Indication, 2020-2027, (USD Million)

Table 28 Western Europe Viral Gastroenteritis Market by End Users, 2020-2027, (USD Million)

Table 29 Eastern Europe Viral Gastroenteritis Market by Type of Virus, 2020-2027, (USD Million)

Table 30 Eastern Europe Viral Gastroenteritis Market by Diagnosis, 2020-2027, (USD Million)

Table 31 Europe Viral Gastroenteritis Market by Drugs 2020-2027, (USD Million)

Table 32 Europe Viral Gastroenteritis Market by Indication, 2020-2027, (USD Million)

Table 33 Eastern Europe Viral Gastroenteritis Market by End Users, 2020-2027, (USD Million)

Table 34 Asia Pacific Viral Gastroenteritis Market by Type of Virus, 2020-2027, (USD Million)

Table 35 Asia Pacific Viral Gastroenteritis Market by Diagnosis, 2020-2027, (USD Million)

Table 36 Asia Pacific Viral Gastroenteritis Market by End Users, 2020-2027, (USD Million)

Table 37 Middle East & Africa Viral Gastroenteritis Market by Type of Virus, 2020-2027, (USD Million)

Table 38 Middle East & Africa Viral Gastroenteritis Market by Diagnosis, 2020-2027, (USD Million)

Table 39 Middle East & Africa Viral Gastroenteritis Market by End Users, 2020-2027, (USD Million)

FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Viral Gastroenteritis Market

Figure 3 Segmentation Market Dynamics for Viral gastroenteritis Market

Figure 4 Global Viral Gastroenteritis Market Share, by Type of Virus 2020

Figure 5 Global Viral Gastroenteritis Market Share, by Diagnosis 2020

Figure 6 Global Viral Gastroenteritis Market Share, by End Users, 2020

Figure 7 Global Viral Gastroenteritis Market Share, by Region, 2020

Figure 8 North America Viral Gastroenteritis Market Share, by Country, 2020

Figure 9 Europe Viral Gastroenteritis Market Share, by Country, 2020

Figure 10 Asia Pacific Viral Gastroenteritis Market Share, by Country, 2020

Figure 11 Middle East & Africa Viral Gastroenteritis Market Share, by Country, 2020

Figure 12 Global Viral Gastroenteritis Market: Company Share Analysis, 2020 (%)

Figure 13 Valeant Pharmaceuticals : Key Financials

Figure 14 Valeant Pharmaceuticals : Segmental Revenue

Figure 16 Valeant Pharmaceuticals : Geographical Revenue

Figure 17 Janssen Biotech Inc.: Key Financials

Figure 18 Janssen Biotech Inc.: Segmental Revenue

Figure 19 Janssen Biotech Inc.: Geographical Revenue

Figure 20 Takeda Pharmaceutical: Key Financials

Figure 21 Takeda Pharmaceutical: Segmental Revenue

Figure 22 Takeda Pharmaceutical: Geographical Revenue

Figure 23 Abbott: Key Financials

Figure 24 Abbott: Segmental Revenue

Figure 25 Abbott: Geographical Revenue

Figure 26 Bayer AG: Key Financials

Figure 27 Bayer AG: Segmental Revenue

Figure 28 Bayer AG: Geographical Revenue

Figure 29 Sanofi: Key Financials

Figure 30 Sanofi: Segmental Revenue

Figure 31 Sanofi: Geographical Revenue

Figure 32 Allergan: Key Financials

Figure 33 Allergan: Segmental Revenue

Figure 34 Allergan: Geographical Revenue